Your browser doesn't support javascript.
loading
The Value of Neoadjuvant Anthracycline-Based Regimens for HER2-Positive Breast Cancer: A Systematic Review and Meta-analysis Including 1366 Patients.
Ding, Yuqin; Ding, Kaijing; He, Xiangming; Mo, Wenju; Liang, Chenlu; Gong, Lijie; Huang, Yuting; Ding, Xiaowen.
Afiliación
  • Ding Y; Department of Breast Surgery, Zhejiang Cancer Hospital, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, China.
  • Ding K; Department of Child psychology, Affiliated Mental Health Center & Hangzhou Seventh People's Hospital, Zhejiang University School of Medicine, Hangzhou, China.
  • He X; Department of Breast Surgery, Zhejiang Cancer Hospital, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, China.
  • Mo W; Department of Breast Surgery, Zhejiang Cancer Hospital, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, China.
  • Liang C; Department of Breast Surgery, Zhejiang Cancer Hospital, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, China.
  • Gong L; Department of Breast Surgery, Zhejiang Cancer Hospital, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, China.
  • Huang Y; Department of Breast Surgery, Zhejiang Cancer Hospital, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, China.
  • Ding X; Department of Oncology, Wenzhou Medical University, Wenzhou, China.
Clin Med Insights Oncol ; 17: 11795549231195293, 2023.
Article en En | MEDLINE | ID: mdl-37744425

Texto completo: 1 Colección: 01-internacional Tipo de estudio: Guideline / Observational_studies / Prognostic_studies / Systematic_reviews Idioma: En Revista: Clin Med Insights Oncol Año: 2023 Tipo del documento: Article País de afiliación: China

Texto completo: 1 Colección: 01-internacional Tipo de estudio: Guideline / Observational_studies / Prognostic_studies / Systematic_reviews Idioma: En Revista: Clin Med Insights Oncol Año: 2023 Tipo del documento: Article País de afiliación: China